Jälgige meid
EE
EE

Üks Life4me+ peamiseid eesmärke on uute HIVi- ja muude sugulisel teel levivate nakkuste juhtumite, nagu ka C-hepatiiti ja tuberkuloosi nakatumise ennetamine.

Nutirakendus aitab luua kontakti arstide ja HIV positiivsete inimeste vahel. Nutirakendus aitab mugavalt organiseerida ravimite võtmise aegu, seadistada ainult Teile arusaadavad ja personaalseid meeldetuletusi, võimaldab saada arstilt tagasisidet ning panna aega vastuvõtule või analüüsidele.

Kõik uudised

Arhiiv

✕
25 detsember 2016
10187
UK: 40% drop in new HIV infections

UK: 40% drop in new HIV infections

The largest sexual health clinic in the UK has reported a dramatic drop in the number of people they have diagnosed with HIV this year.
22 detsember 2016
10072
Janssen Sciences: Investigational two-drug HIV regimen showed positive results

Janssen Sciences: Investigational two-drug HIV regimen showed positive results

Janssen Sciences Ireland UC (Janssen) announced the results from first phase III studies of investigational two-drug HIV treatment regimen. Two Phase III studies were designed to evaluate the safety and efficacy of switching virologically suppressed patients from a three ...
21 detsember 2016
11327
Study: Drugs for HIV and Hepatitis C treatment can cause side effects when used together

Study: Drugs for HIV and Hepatitis C treatment can cause side effects when used together

Study: Use of direct-acting antivirals for the treatment of Hepatitis C virus infection, which contain sofosbuvir can lead to Hepatitis B reactivation in the body, as well as to interact with HIV drug tenofovir disoproxil.
21 detsember 2016
12610
GSK to test injectable drug for PrEP

GSK to test injectable drug for PrEP

GlaxoSmithKline had started a large study to test an experimental long-acting injection for preventing of HIV infection. The drug cabotegravir, an injectable medication, which if effective might become an alternative to Truvada.
21 detsember 2016
11738
Study: Drugs for HIV and Hepatitis C treatment can cause side effects when used together

Study: Drugs for HIV and Hepatitis C treatment can cause side effects when used together

According to a study published by University of Rhode Island pharmacy professor and a graduate student in the Journal of Hepatology, use of direct-acting antivirals for the treatment of Hepatitis C virus infection , such as Sovaldi, Harvoni and Epclusa, which contain sofosbuvir ...
20 detsember 2016
12127
Dolutegravir quickly reduces viral load in semen

Dolutegravir quickly reduces viral load in semen

According to the new study published in the Journal of Infectious Diseases, dolutegravir (Tivicay) is able to dramatically reduce the viral load in semen. Semen is thought to be a reservoir of the virus and other antiviral drugs have difficult time reaching this area. It ...
20 detsember 2016
9662
Study: sex-race health disparities in the occurrence of chronic diseases associated with ageing

Study: sex-race health disparities in the occurrence of chronic diseases associated with ageing

A group of researchers from the United States have published the results of a study regarding ART-treated people and sex-race disparities in the occurrence of chronic diseases associated with ageing. The study was published in the online edition of Clinical Infectious Diseases. ...
19 detsember 2016
10380
Ibalizumab might be the answer for patients with drug resistance

Ibalizumab might be the answer for patients with drug resistance

According to the results from a Phase 3 trial published in October, an experimental injectable drug, ibalizumab, might be an option for patients struggling with drug resistance. Drug resistant strains are now a major threat to effective HIV treatment worldwide. Patients ...
19 detsember 2016
7351
Study: HIV treatment can cause neuronal damage

Study: HIV treatment can cause neuronal damage

Despite antiretroviral drugs play a crucial role in HIV treatment for HIV -infected people, they can have major side effects. Researchers from the University of Pennsylvania have been published a study in the American Journal of Pathology. According to the study some protease ...
16 detsember 2016
8076
‘HIV Undetectable’ must equal ‘Untransmittable’ and the science proves it

‘HIV Undetectable’ must equal ‘Untransmittable’ and the science proves it

Dr.Rich Wolitski, Acting Director for the Office for HIV/AIDS and Infectious Disease Policy at the U.S. Department of Health and Human Services and person living with HIV has delivered his speech at the 2016 United States Conference on AIDS (USCA), regarding recent studies ...
Kasutusmugavuse parendamiseks rakendab veebileht küpsiseid.
Lehel mis tahes nuppu klõpsates nõustute küpsiste kasutamisega.